시장보고서
상품코드
1193133

세계의 판클레리파제 시장 : 용도별, 연령별, 유통 채널별-기회 분석, 산업 예측(2021-2031년)

Pancrelipase Market By Application, By Age, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 157 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

판클레리파제(Pancrelipase) 시장은 2021년에 17억 6,041만 달러였으며, 2031년에는 26억 8,739만 달러에 달할 것으로 예상되며, 2022년부터 2031년까지 CAGR 4.3%로 성장할 것으로 예측됩니다.

펑클레리파제의 제조에는 정제 돼지 췌장 리파아제, 아밀라아제, 프로테아제 효소가 사용됩니다. 낭포성 섬유증이나 췌장염과 같은 췌장이 제대로 작동하지 않는 질병에서는 음식을 소화하는 데 도움이 되는 펑클레리파제가 사용됩니다. 판크렐리파제에 포함된 리파아제, 프로테아제, 아밀라아제는 단백질, 탄수화물, 지질의 분해에 필요합니다.

판클레리파아제 시장의 성장을 촉진하는 주요 요인은 만성 췌장염의 유병률 증가, 낭포성 섬유증 및 식습관 및 라이프 스타일의 변화 등이 있습니다. 또한 주로 췌장의 기능 장애가 시장의 주요 추세이며 예측 기간 동안 성장을 촉진 할 것으로 예상됩니다. 만성 췌장염 또는 장기간 지속되는 췌장염은 일부 사람들에게 발생할 수 있습니다. 성인 만성 췌장염 환자와 췌장 절제 수술을 받은 환자는 양성자 펌프 억제제(PPI)와 함께 사용된 펑클레리파제 제제를 복용하여 음식 소화를 촉진할 수 있습니다. 췌장염 발생률 증가는 시장 성장을 촉진합니다.

소화기계 질환의 유병률 상승은 펑클레리파제 시장을 구동합니다. 인스턴스에 대한 NCBI, 생명 공학 정보를위한 국립 센터에 따르면, 소화기 질환은 매년 미국에서 추정 6,000만에서 7,000만명에게 영향을 미칩니다. 이와 같이 전세계에서 소화기계 질환의 유병률이 높아지고 있으며, 이것이 더욱 판클레리파아제 의약품의 필요성을 강조하고 시장의 성장을 일으키고 있습니다.

그러나 의약품 개발과 관련된 막대한 비용과 브랜드 약물 특허가 시장 성장을 방해 할 것으로 예상됩니다. 한편, 소비자의 필요성를 충족시키는 신흥 시장의 성장 기회는 투자자에게 큰 투자 기회가 될 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter’s Five Forces
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 판크렐리파제 시장 : 용도별

  • 개요
    • 시장 규모 및 예측
  • 만성 췌장염
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 낭포성 섬유증
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별

제5장 판크렐리파제 시장 : 연령별

  • 개요
    • 시장 규모 및 예측
  • 어린이
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 성인·노년
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별

제6장 펑클레리파제 시장 : 유통 채널별

  • 개요
    • 시장 규모 및 예측
  • 병원 약국
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 약국·소매 약국
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 온라인 약국
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별

제7장 판클레리파제 시장 : 지역별

  • 개요
    • 시장 규모 및 예측
  • 북미
    • 주요 동향 및 기회
    • 북미의 시장 규모 및 예측 : 용도별
    • 북미의 시장 규모 및 예측 : 연령별
    • 북미의 시장 규모 및 예측 : 유통 채널별
    • 북미의 시장 규모 및 예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향 및 기회
    • 유럽의 시장 규모 및 예측 : 용도별
    • 유럽의 시장 규모 및 예측 : 연령별
    • 유럽의 시장 규모 및 예측 : 유통 채널별
    • 유럽의 시장 규모 및 예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 기타 유럽 지역
  • 아시아 태평양 지역
    • 주요 동향 및 기회
    • 아시아 태평양 지역의 시장 규모 및 예측 : 용도별
    • 아시아 태평양 지역의 시장 규모 및 예측 : 연령별
    • 아시아 태평양 지역의 시장 규모 및 예측 : 유통 채널별
    • 아시아 태평양 지역의 시장 규모 및 예측 : 국가별
      • 일본
      • 중국
      • 인도
      • 호주
      • 기타 아시아 태평양 지역
  • LAMEA
    • 주요 동향 및 기회
    • LAMEA의 시장 규모 및 예측 : 용도별
    • LAMEA의 시장 규모 및 예측 : 연령별
    • LAMEA의 시장 규모 및 예측 : 유통 채널별
    • LAMEA의 시장 규모 및 예측 : 국가별
      • 남미
      • 중동 및 아프리카

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 개요

  • Abbvie Inc
  • Digestive Care, Inc.
  • Nestle SA
  • Organon Canada Inc.
  • Viatris Inc.
  • Vivus Llc
LSH 23.03.13

The global pancrelipase market was valued at $1,760.41 million in 2021, and is estimated to reach $2,687.39 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.

Purified porcine pancreatic lipase, amylase, and protease enzymes are used to make pancrelipase. In diseases where the pancreas is not functioning properly, such as cystic fibrosis and pancreatitis, pancrelipase is utilized to aid in improving food digestion. The lipases, proteases, and amylases included in pancrelipase are necessary for the breakdown of proteins, carbohydrates, and lipids.

The major factors that drive the growth of the pancrelipase market is increase in the increase in prevalence of chronic pancreatitis, cystic fibrosis and changing dietary habits &lifestyle, are the factors attributed to the growth of the pancrelipase market. In addition, primarily pancreatic insufficiency is a key trend of the market which is expected to fuel the growth in the forecast period.The pancreas is inflamed by pancreatitis. Chronic pancreatitis, or pancreatitis that lasts for a long time, can occur in some persons. Adults with chronic pancreatitis or those who have undergone pancreas removal surgery can enhance their food digestion by taking pancrelipase pills coupled with a proton pump inhibitor (PPI). Increase in incidence of the pancreatitis drives the market growth. 

Rise in prevalence of the digestive diseases drives pancrelipase market. For an instance According to the NCBI, National Center for Biotechnology Information, gastrointestinal diseases affect an estimated 60 to 70 million people annually in America. Thus, there is a growing prevalence of the digestive diseases around the globe which further highlights the need for the pancrelipase drugs causing the market growth

However high cost associated with drug development, patents of the branded drugs are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.

The global pancrelipase market is segmented on the basis of application, age, distribution channel and region. On the basis of application, the market is categorized into chronic pancreatitis, cystic fibrosis and others. By age, it is segmented into children and adult & geriatric. By distribution channel, it is segmented into hospital pharmacies, drug store and retail pharmacies and online pharmacies. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).

The major players profiled in the report are Abbvie Inc, Digestive Care, Inc, Nestle S.A., Organon Canada Inc., Viatris Inc., and Vivus LLC.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pancrelipase market analysis from 2021 to 2031 to identify the prevailing pancrelipase market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pancrelipase market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pancrelipase market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Age

  • Children
  • Adults and Geriatrics

By Application

  • Chronic Pancreatitis
  • Cystic Fibrosis
  • Others

By Distribution Channel

  • Online Pharmacies
  • Hospital Pharmacies
  • Drug Store and Retail Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East Africa
  • Key Market Players
    • Abbvie Inc
    • Digestive Care, Inc.
    • Nestle S.A
    • Organon Canada Inc.
    • Viatris Inc.
    • Vivus Llc

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PANCRELIPASE MARKET, BY APPLICATION

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Chronic Pancreatitis
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Cystic Fibrosis
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4 Others
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country

CHAPTER 5: PANCRELIPASE MARKET, BY AGE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Children
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Adults and Geriatrics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospital Pharmacies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Drug Store and Retail Pharmacies
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Online Pharmacies
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: PANCRELIPASE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Application
    • 7.2.3 North America Market size and forecast, by Age
    • 7.2.4 North America Market size and forecast, by Distribution Channel
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by Age
      • 7.2.5.1.4 Market size and forecast, by Distribution Channel
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by Age
      • 7.2.5.2.4 Market size and forecast, by Distribution Channel
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by Age
      • 7.2.5.3.4 Market size and forecast, by Distribution Channel
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Application
    • 7.3.3 Europe Market size and forecast, by Age
    • 7.3.4 Europe Market size and forecast, by Distribution Channel
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by Age
      • 7.3.5.1.4 Market size and forecast, by Distribution Channel
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by Age
      • 7.3.5.2.4 Market size and forecast, by Distribution Channel
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by Age
      • 7.3.5.3.4 Market size and forecast, by Distribution Channel
      • 7.3.5.4 Rest of Europe
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by Age
      • 7.3.5.4.4 Market size and forecast, by Distribution Channel
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Application
    • 7.4.3 Asia-Pacific Market size and forecast, by Age
    • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by Age
      • 7.4.5.1.4 Market size and forecast, by Distribution Channel
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by Age
      • 7.4.5.2.4 Market size and forecast, by Distribution Channel
      • 7.4.5.3 India
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by Age
      • 7.4.5.3.4 Market size and forecast, by Distribution Channel
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by Age
      • 7.4.5.4.4 Market size and forecast, by Distribution Channel
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by Age
      • 7.4.5.5.4 Market size and forecast, by Distribution Channel
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Application
    • 7.5.3 LAMEA Market size and forecast, by Age
    • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Latin America
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by Age
      • 7.5.5.1.4 Market size and forecast, by Distribution Channel
      • 7.5.5.2 Middle East & Africa
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by Age
      • 7.5.5.2.4 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbvie Inc
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Digestive Care, Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Nestle S.A
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Organon Canada Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Viatris Inc.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Vivus Llc
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제